000131352 001__ 131352
000131352 005__ 20241125101158.0
000131352 0247_ $$2doi$$a10.37201/req/078.2023
000131352 0248_ $$2sideral$$a136432
000131352 037__ $$aART-2023-136432
000131352 041__ $$amul
000131352 100__ $$aBouza, E.
000131352 245__ $$aRecommendations for the prevention of healthcare-associated infections in nursing homes
000131352 260__ $$c2023
000131352 5060_ $$aAccess copy available to the general public$$fUnrestricted
000131352 5203_ $$aNursing homes (NH) conceptually should look as much like a home as possible. However NH have unquestionable similarities with a nosocomium as they are places where many patients with underlying diseases and comorbidities accumulate. There is evidence of transmission of microorganisms between residents and between residents and caregivers. We have not found any recommendations specifically aimed at the prevention of nosocomial infections in NH by the major Public Health Agencies and, therefore, the Health Sciences Foundation (Fundación de Ciencias de la Salud) has convened a series of experts and 14 Spanish scientific societies to discuss recommendations that could guide NH personnel in establishing written programs for the control and reduction of these infections. The present document is the result of these deliberations and contains suggestions for establishing such control programs on a voluntary and flexible basis in NH. We also hope that the document can help the health authorities to encourage this control activity in the different territorial areas of Spain. In our opinion, it is necessary to draw up a written plan and establish the figure of a coordinator or person responsible for implementing these projects. The document includes
measures to be implemented and ways of quantifying the reality of different problems and of monitoring the impact of the measures established.
000131352 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000131352 590__ $$a1.9$$b2023
000131352 592__ $$a0.399$$b2023
000131352 591__ $$aPHARMACOLOGY & PHARMACY$$b231 / 354 = 0.653$$c2023$$dQ3$$eT2
000131352 593__ $$aMedicine (miscellaneous)$$c2023$$dQ3
000131352 591__ $$aMICROBIOLOGY$$b130 / 161 = 0.807$$c2023$$dQ4$$eT3
000131352 593__ $$aPharmacology$$c2023$$dQ3
000131352 593__ $$aMicrobiology (medical)$$c2023$$dQ3
000131352 594__ $$a2.9$$b2023
000131352 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000131352 700__ $$aAsensio, A.
000131352 700__ $$aGarcía Navarro, J.A.
000131352 700__ $$aGonzalez, P.
000131352 700__ $$aAcosta Benito, M.A.
000131352 700__ $$aAguilar, J.
000131352 700__ $$aBarberan, J.
000131352 700__ $$aCabrera, J.
000131352 700__ $$0(orcid)0000-0002-3132-2171$$aDiez-Manglano, J.$$uUniversidad de Zaragoza
000131352 700__ $$aFernández, Carlos
000131352 700__ $$aFernandez-Prada, María
000131352 700__ $$aFontán, Guadalupe
000131352 700__ $$aCisneros, José Miguel
000131352 700__ $$aLorenzo-Vidal, Belén
000131352 700__ $$aMartín Oliveros, Adela
000131352 700__ $$aNavas, Paloma
000131352 700__ $$aPalomo, Esteban
000131352 700__ $$aKestler, Martha
000131352 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000131352 773__ $$g36, 6 (2023), 552-561$$pRev. esp. quimioter.$$tRevista española de quimioterapia$$x0214-3429
000131352 8564_ $$s184812$$uhttps://zaguan.unizar.es/record/131352/files/texto_completo.pdf$$yVersión publicada
000131352 8564_ $$s2885577$$uhttps://zaguan.unizar.es/record/131352/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000131352 909CO $$ooai:zaguan.unizar.es:131352$$particulos$$pdriver
000131352 951__ $$a2024-11-22-12:10:24
000131352 980__ $$aARTICLE